Status: Not yet recruiting
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
The purpose of this Interventional clinical trial is to evaluate safety and efficacy of 'IMD10 (focused ultrasound)' in the treatment of borderline resectable pancreatic cancer or locally advanced pancreatic cancer.
Participants needed: 360
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: IMGT Co., Ltd.Updated: Jul 15, 2026Locations: 5
Eligibility criteria
2. Aged between 18 and 85 years, inclusive [+10]
1. The presence of a cystic lesion within tumor to be treated, or at the pancrea... [+18]